Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Employee Orientation: The 90 Day Difference

Tags

  • drugs
  • issues
  • product
  • combination products
  • companies involved

  • Links

  • Beat the Credit Card Blues: 5 Super Strategies To Eliminate Dangerous Spending Habits
  • The Rich Jerk Revealed
  • How's Your Sense of Style?
  • Digg It - Employee Orientation: The 90 Day Difference

    Why do some new managers succeed while others fail? It all depends on the first th
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ree months – the critical time when the new hire is learning the ropes. The new ma
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    nager’s boss plays a vital role in the orientation process. Here are four stra
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    tegies to quickly get the new hire up to speed and working productively

    Cl
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    arify goals and priorities.
    What are the performance expectations and d
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    eliverables for you and your team? How is performance going to be measured/succes
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    s evaluated? What are the key business issues that you need to focus on?

    Defi
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ne responsibility and accountability.
    How much operational freedom/auto
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    nomy is there? What types of decisions require approval, consulting, or advising,
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    and/or are subject to veto? Who else is significantly involved in any decision-
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    making? On what basis?

    Agree on communication.
    What is the frequenc
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    y and type of preferred communications? Is it regular meetings? Written, e-mail r
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    eports? Event-based communications?

    Identify current 'hot issues'.
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    What do you need to watch out for? For example: Relationships among team member
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    s; client histories and experiences with the company; operating and performance pr
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    oblems.

    The good news is that orientation offers an opportunity to build a lastin
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    g impression of the new company. The bad news is that that is going to happen whet
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    her you plan it or not.

    Make sure you get your new managers off to a great start.
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    Employee orientation, whether it takes one hour or one day, is a critical opport
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    unity – don’t waste it. What’s your orientation program like? Do you even have one


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/24284/diggit-Employee-Orientation-The-90-Day-Difference.html">Employee Orientation: The 90 Day Difference</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/24284/diggit-Employee-Orientation-The-90-Day-Difference.html]Employee Orientation: The 90 Day Difference[/url]

    Related Articles:

    3 Ways to be (Somewhat) Predictable

    Momentum and Branding

    Forget Culture, Change Behaviours

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com